Albert Lung is of counsel in Morgan Lewis's Business and Finance Practice. Mr. Lung's practice concentrates on capital market transactions, corporate governance, and securities laws. His practice focuses on representing companies, investment banks, and major stakeholders in a variety of corporate finance transactions, including IPOs, follow-on and secondary offerings, PIPEs, Rule 144A offerings, and convertible debt financing. Mr. Lung also counsels publicly listed companies, including technology, biotech, software, and life science companies on corporate governance, SEC regulations, legal compliance, NYSE and NASDAQ listing requirements, investors communications, and general corporate matters. His practice also includes advising companies located in the Asia-Pacific region in cross-border financing transactions and compliance with U.S. securities laws and disclosure requirements. Mr. Lung has represented clients in venture financing transactions, mergers and acquisitions, and other commercial transactions for companies in a variety of industries, with a focus on representing emerging technology and life science companies in the Silicon Valley.

Prior to joining Morgan Lewis, Mr. Lung was an associate at a leading business and finance law firm in New York, where his practice included capital market transactions, secured financing, and advising private equity funds on matters relating to securities and corporate law.

Mr. Lung earned his J.D., magna cum laude, from Yeshiva University, Benjamin N. Cardozo School of Law in 2001, where he was the managing editor for the Cardozo Law Review and authored an article titled "Must-Carry Rules in the Transition to Digital Television: A Delicate Constitutional Balance." He earned his B.A., summa cum laude, in political science from New York University in 1998.

Mr. Lung is admitted to practice in California and New York.